Each ARSYNL Rx plan begins with an online consultation, ensuring proper dosing and follow-up for qualified patients
of the CY 2026 OPPS/ASC proposed rule (Proposed Payment for Nonpass-Through Drugs, Biologicals, and Radiopharmaceuticals with HCPCS Codes but Without OPPS Hospital Claims Data), we proposed to set the payment rate for new diagnostic radiopharmaceuticals that exceed the diagnostic radiopharmaceutical packaging threshold and with HCPCS codes, but which do not have pass-through status and are without claims data, at ASP plus 6 percent (90 FR 33624)
Lenny Macrina: Right, and they talk about swelling, joint pain, anxiety, panic attacks, heart palpitations, insomnia, drowsiness, weakness, fatigue, loss of appetite, depression, anhedonia
A legitimate CoA comes from an independent lab (not the vendor's in-house lab)
How AOD-9604 Compares to Other Metabolic Support Peptides Understanding how AOD-9604 compares to other metabolic support compounds helps determine which option best aligns with individual goals, health status, and preferences
